FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Warrington

Research Profile

Living Beings

Physiology

Chemicals & Drugs

Procedures

Genetic Therapy

Anatomy

Genes & Molecular Sequences

Transgenes

Devices

Gene Transfer Techniques

Co-author Network

Publications

TOP 3
Katharine Laughlin; Defang Luo; Che Liu; Gerry Shaw; Kenneth H Warrington; Jingxin Qiu; Anthony T Yachnis; Jeffrey K Harrison
Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas.
Katharine Laughlin; Defang Luo; Che Liu; Gerry Shaw; Kenneth H Warrington; Brian K Law; Jeffrey K Harrison
Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest.
Hazel C Levy; valorie bowman; Lakshmanan Govindasamy; Robert McKenna; Kevin Nash; Kenneth H Warrington; Weijun Chen; Nicholas Muzyczka; Xiaodong Yan; Timothy S Baker; Mavis Agbandje-McKenna
Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Warrington (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Katharine Laughlin; Defang Luo; Che Liu; Gerry Shaw; Kenneth H Warrington; Jingxin Qiu; Anthony T Yachnis; Jeffrey K Harrison
Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas.
Pathology oncology research : POR 2009;15(3):437-44.
2009: Katharine Laughlin; Defang Luo; Che Liu; Gerry Shaw; Kenneth H Warrington; Brian K Law; Jeffrey K Harrison
Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest.
Differentiation; research in biological diversity 2009;78(1):35-44.
2009: Hazel C Levy; valorie bowman; Lakshmanan Govindasamy; Robert McKenna; Kevin Nash; Kenneth H Warrington; Weijun Chen; Nicholas Muzyczka; Xiaodong Yan; Timothy S Baker; Mavis Agbandje-McKenna
Heparin binding induces conformational changes in Adeno-associated virus serotype 2.
Journal of structural biology 2009;165(3):146-56.
2008: Li Zhong; Baozheng Li; Cathryn Mah; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Mario Cooper; Roland W Herzog; Irene Zolotukhin; Kenneth H Warrington; Kirsten A Weigel-Van Aken; Jacqueline A Hobbs; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava
Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(22):7827-32.
2007: Jianqing Wu; Weihong Zhao; Li Zhong; Zongchao Han; Baozheng Li; Wenqin Ma; Kirsten A Weigel-Kelley; Kenneth H Warrington; Arun Srivastava
Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.
Human gene therapy 2007;18(2):171-82.
2006: Weihong Zhao; Li Zhong; Jianqing Wu; Linyuan Chen; Keyun Qing; Kirsten A Weigel-Kelley; Steven H Larsen; Weinian Shou; Kenneth H Warrington; Arun Srivastava
Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors.
Virology 2006;353(2):283-93.
2006: Kenneth H Warrington; Roland W Herzog
Treatment of human disease by adeno-associated viral gene transfer.
Human genetics 2006;119(6):571-603.
2006: Li Zhong; Weiming Li; Yanjun Li; Weihong Zhao; Jianqing Wu; Baozheng Li; Njeri Maina; Daniela Bischof; Keyun Qing; Kirsten A Weigel-Kelley; Irene Zolotukhin; Kenneth H Warrington; Xiaomiao Li; William B Slayton; Mervin C Yoder; Arun Srivastava
Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
Human gene therapy 2006;17(3):321-33.
2006: Christian Teschendorf; Kenneth H Warrington; Wenyin Shi; Dietmar W Siemann; Nicholas Muzyczka
Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma.
Anticancer research 2006;26(1A):311-7.
2005: Erik Kohlbrenner; George Aslanidi; Kevin Nash; Stanislav Shklyaev; Martha Campbell-Thompson; Barry J Byrne; Richard O Snyder; Nicholas Muzyczka; Kenneth H Warrington; Sergei Zolotukhin
Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(6):1217-25.
2005: Laure Gigout; Patricia Rebollo; Nathalie Clement; Kenneth H Warrington; Nicholas Muzyczka; R Michael Linden; Thomas Weber
Altering AAV tropism with mosaic viral capsids.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(6):856-65.
2005: Nicholas Muzyczka; Kenneth H Warrington
Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
Human gene therapy 2005;16(4):408-16.
2004: Kenneth H Warrington; Oleg S Gorbatyuk; Jeffrey K Harrison; Shaun R Opie; Sergei Zolotukhin; Nicholas Muzyczka
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
Journal of virology 2004;78(12):6595-609.
2003: Scott A Loiler; Thomas J Conlon; Sihong Song; Qiushi Tang; Kenneth H Warrington; Anupam Agarwal; Matthias H Kapturczak; Chengwen Li; Camillo Ricordi; Mark A Atkinson; Nicholas Muzyczka; Terence R Flotte
Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver.
Gene therapy 2003;10(18):1551-8.
2003: Shaun R Opie; Kenneth H Warrington; Mavis Agbandje-McKenna; Sergei Zolotukhin; Nicholas Muzyczka
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.
Journal of virology 2003;77(12):6995-7006.
2002: Christian Teschendorf; Kenneth H Warrington; Dietmar W Siemann; Nicholas Muzyczka
Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
Anticancer research 2002;22(6A):3325-30.
2002: Wu Xiao; Kenneth H Warrington; Patrick Hearing; Jeffrey Hughes; Nicholas Muzyczka
Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2.
Journal of virology 2002;76(22):11505-17.
2000: Dietmar W Siemann; Kenneth H Warrington; Michael R Horsman
Targeting tumor blood vessels: an adjuvant strategy for radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;57(1):5-12.
1998: Kenneth H Warrington; Christian Teschendorf; L Cao; Nicholas Muzyczka; Dietmar W Siemann
Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid.
International journal of radiation oncology, biology, physics 1998;42(4):909-12.